DarioHealth Corp. (DRIO) financial statements and ratios from SEC XBRL: revenue $22.36M (TTM), net margin -186.6%, revenue growth -3.6% YoY, P/E 0.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $22.36M |
| Net Margin | -186.6% |
| Return on Equity | -64.8% |
| Debt / Equity | 0.66 |
| Current Ratio | 2.31 |
| Revenue Growth (YoY) | -3.6% |
| EPS Growth (YoY) | 372.2% |
| FCF Growth (YoY) | 0.8% |
| P/E Ratio | 0.6 |
| EV / EBITDA | -3.3 |
| Price / Book | 1.33 |
| Price / Sales | 3.50 |
| FCF Yield | -34.7% |
| Altman Z-Score | -5.59 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
DRIO overview · DRIO earnings · DRIO KPIs · DRIO investor relations · DRIO ownership · DRIO peers · DRIO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.